A CD4 testing machine. Research by the University of Zimbabwe shows that female patients with high CD4 counts have developed a nevirapine toxicity. Credit: Jennifer Mckellar/IPS
CAPE TOWN, South Africa, Dec 9 2013 (IPS) – New research suggests that some AIDS patients are developing drug intolerance and severe side effects and will now have to switch to new, more expensive antiretroviral regimens.
Researchers in Zimbabwe, Uganda, Nigeria and Malawi say some patients on the first-line antiretroviral drugs nevirapine and efavirenz (EFZ) are showing signs of being intolerant to the two drugs.
Daniel Sibanda, a University of Zimbabwe researcher, said whil…